Bio-Techne Cp Cmn (TECH) 106.88 $TECH Bio-Techn
Post# of 273257
Posted On: 09/03/2016 11:08:34 AM
Bio-Techne Cp Cmn (TECH) 106.88 $TECH
Bio-Techne Announces Investor Day And Webcast
PR Newswire - Wed Aug 31, 8:35AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.
TECH: 106.88 (+0.35)
RSI Alert: Bio-Techne (TECH) Now Oversold
MarketNewsVideo.com - Wed Aug 24, 3:32PM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
TECH: 106.88 (+0.35)
Bio-Techne Declares Dividend
PR Newswire - Wed Aug 17, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2016. The quarterly dividend will be payable September 12, 2016 to all common shareholders of record on August 29, 2016. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
TECH: 106.88 (+0.35)
Medical Stocks' Earnings to Watch Next Week: TECH, WVE, EARS
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:21AM CDT
How will medical stocks Bio-Techne, WAVE Life Sciences, and Auris perform this earnings season?
WVE: 24.99 (+1.71), EARS: 1.71 (unch), TECH: 106.88 (+0.35)
Uptrend Call Working As Techne Stock Rises 26.8% (TECH)
Comtex SmarTrend(R) - Tue Aug 09, 1:29PM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 26.82% as of today's recent price of $111.49.
TECH: 106.88 (+0.35)
Bio-Techne To Host Conference Call On August 17, 2016 To Announce Fourth Quarter Financial Results
PR Newswire - Wed Aug 03, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Wednesday, August 17, 2016, at 8:00 a.m. CDT to review fourth quarter fiscal 2016 financial results.
TECH: 106.88 (+0.35)
ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:54AM CDT
Investor focus will remain on the performance of ACADIA's (ACAD) recently launched Nuplazid.
ACAD: 31.59 (-0.51), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), XLRN: 30.84 (+0.59)
Ligand (LGND) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:18AM CDT
Our proven model does not conclusively show that Ligand (LGND) is likely to beat earnings estimates this quarter.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), LGND: 106.19 (-0.85), XLRN: 30.84 (+0.59)
Teva (TEVA): Stock Likely to Beat on Earnings in Q2 Again?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:06AM CDT
Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
AGN: 235.96 (-1.80), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), TEVA: 51.22 (+0.32)
Juno (JUNO) Q2 Earnings: Will the Stock Disappoint?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 5:49AM CDT
With no approved products in its portfolio, focus will remain on Juno's (JUNO) pipeline and cash burn.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), JUNO: 28.44 (-0.85), CELG: 105.49 (-0.88)
Techne Has Returned 29.4% Since SmarTrend Recommendation (TECH)
Comtex SmarTrend(R) - Tue Aug 02, 12:56AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 29.43% as of today's recent price of $113.78.
TECH: 106.88 (+0.35)
Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics
PR Newswire - Mon Aug 01, 4:27PM CDT
Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA. This represents the 9th acquisition for Bio-Techne in the last three years. With these acquisitions, Minneapolis-based Bio-Techne has grown from approximately 650 employees in 2013 to nearly 1,700 staff worldwide and has expanded its global reach with subsidiaries in every major geographic market. Organically, we continue to develop and launch in excess of 1,500 new products to market on a yearly basis which enable researchers to address new and more complex questions in the life science field. This latest acquisition of ACD is consistent with our strategic plan, which includes both organic growth and acquisitions that fill portfolio gaps.
TECH: 106.88 (+0.35)
Techne Up 28.4% Since SmarTrend Uptrend Call (TECH)
Comtex SmarTrend(R) - Wed Jun 08, 1:04AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 28.45% as of today's recent price of $112.92.
TECH: 106.88 (+0.35)
Watch for Techne to Potentially Pullback After Gaining 2.36% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:18PM CDT
Techne (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $106.43 to a high of $109.93. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $108.18 on volume of 111,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TECH: 106.88 (+0.35)
Techne Shares Up 19.6% Since SmarTrend's Buy Recommendation (TECH)
Comtex SmarTrend(R) - Tue May 24, 1:28AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 19.55% as of today's recent price of $105.10.
TECH: 106.88 (+0.35)
TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 4.96 (unch), TECH: 106.88 (+0.35), EXAC: 27.90 (+0.10), NVRO: 95.91 (-0.11)
Bio-Techne (TECH): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:38AM CDT
Are you a technical investor? If so, it may be time to consider Bio-Techne Corp. (TECH) for your portfolio
TECH: 106.88 (+0.35)
Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology
PR Newswire - Wed May 04, 5:00AM CDT
Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration agreement which gives Bio-Techne access to gene editing technology.
TECH: 106.88 (+0.35)
Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Wed May 04, 3:13AM CDT
Techne (NASDAQ:TECH) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $100.55 on volume of 595,000 shares, above average daily volume of 231,000. Techne Corporation, through Research and Diagnostic Systems, Inc., manufactures biological products. The Company also, through R&D Systems Europe, Ltd., distributes biotechnology products.
TECH: 106.88 (+0.35)
Bio-Techne Announces Investor Day And Webcast
PR Newswire - Wed Aug 31, 8:35AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.
TECH: 106.88 (+0.35)
RSI Alert: Bio-Techne (TECH) Now Oversold
MarketNewsVideo.com - Wed Aug 24, 3:32PM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
TECH: 106.88 (+0.35)
Bio-Techne Declares Dividend
PR Newswire - Wed Aug 17, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2016. The quarterly dividend will be payable September 12, 2016 to all common shareholders of record on August 29, 2016. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
TECH: 106.88 (+0.35)
Medical Stocks' Earnings to Watch Next Week: TECH, WVE, EARS
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:21AM CDT
How will medical stocks Bio-Techne, WAVE Life Sciences, and Auris perform this earnings season?
WVE: 24.99 (+1.71), EARS: 1.71 (unch), TECH: 106.88 (+0.35)
Uptrend Call Working As Techne Stock Rises 26.8% (TECH)
Comtex SmarTrend(R) - Tue Aug 09, 1:29PM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 26.82% as of today's recent price of $111.49.
TECH: 106.88 (+0.35)
Bio-Techne To Host Conference Call On August 17, 2016 To Announce Fourth Quarter Financial Results
PR Newswire - Wed Aug 03, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Wednesday, August 17, 2016, at 8:00 a.m. CDT to review fourth quarter fiscal 2016 financial results.
TECH: 106.88 (+0.35)
ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:54AM CDT
Investor focus will remain on the performance of ACADIA's (ACAD) recently launched Nuplazid.
ACAD: 31.59 (-0.51), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), XLRN: 30.84 (+0.59)
Ligand (LGND) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:18AM CDT
Our proven model does not conclusively show that Ligand (LGND) is likely to beat earnings estimates this quarter.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), LGND: 106.19 (-0.85), XLRN: 30.84 (+0.59)
Teva (TEVA): Stock Likely to Beat on Earnings in Q2 Again?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:06AM CDT
Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
AGN: 235.96 (-1.80), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), TEVA: 51.22 (+0.32)
Juno (JUNO) Q2 Earnings: Will the Stock Disappoint?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 5:49AM CDT
With no approved products in its portfolio, focus will remain on Juno's (JUNO) pipeline and cash burn.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), JUNO: 28.44 (-0.85), CELG: 105.49 (-0.88)
Techne Has Returned 29.4% Since SmarTrend Recommendation (TECH)
Comtex SmarTrend(R) - Tue Aug 02, 12:56AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 29.43% as of today's recent price of $113.78.
TECH: 106.88 (+0.35)
Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics
PR Newswire - Mon Aug 01, 4:27PM CDT
Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA. This represents the 9th acquisition for Bio-Techne in the last three years. With these acquisitions, Minneapolis-based Bio-Techne has grown from approximately 650 employees in 2013 to nearly 1,700 staff worldwide and has expanded its global reach with subsidiaries in every major geographic market. Organically, we continue to develop and launch in excess of 1,500 new products to market on a yearly basis which enable researchers to address new and more complex questions in the life science field. This latest acquisition of ACD is consistent with our strategic plan, which includes both organic growth and acquisitions that fill portfolio gaps.
TECH: 106.88 (+0.35)
Techne Up 28.4% Since SmarTrend Uptrend Call (TECH)
Comtex SmarTrend(R) - Wed Jun 08, 1:04AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 28.45% as of today's recent price of $112.92.
TECH: 106.88 (+0.35)
Watch for Techne to Potentially Pullback After Gaining 2.36% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:18PM CDT
Techne (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $106.43 to a high of $109.93. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $108.18 on volume of 111,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TECH: 106.88 (+0.35)
Techne Shares Up 19.6% Since SmarTrend's Buy Recommendation (TECH)
Comtex SmarTrend(R) - Tue May 24, 1:28AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 19.55% as of today's recent price of $105.10.
TECH: 106.88 (+0.35)
TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 4.96 (unch), TECH: 106.88 (+0.35), EXAC: 27.90 (+0.10), NVRO: 95.91 (-0.11)
Bio-Techne (TECH): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:38AM CDT
Are you a technical investor? If so, it may be time to consider Bio-Techne Corp. (TECH) for your portfolio
TECH: 106.88 (+0.35)
Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology
PR Newswire - Wed May 04, 5:00AM CDT
Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration agreement which gives Bio-Techne access to gene editing technology.
TECH: 106.88 (+0.35)
Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Wed May 04, 3:13AM CDT
Techne (NASDAQ:TECH) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $100.55 on volume of 595,000 shares, above average daily volume of 231,000. Techne Corporation, through Research and Diagnostic Systems, Inc., manufactures biological products. The Company also, through R&D Systems Europe, Ltd., distributes biotechnology products.
TECH: 106.88 (+0.35)
(0)
(0)Scroll down for more posts ▼